Study of the antinociceptive activity of fluoxetine and its interaction with morphine and naloxone in mice

Indian Journal of Pharmacology

Volumn 36, Issue 6, 2004, Pages 369-372

  Kurlekar, P N ^a   Bhatt, Jagat D ^a  

^a Baroda Medical College   (India)

Author keywords

Analgesia; Opioids; SSRI

Indexed keywords

FLUOXETINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HYPERALGESIA; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PAIN; TAIL FLICK TEST;

EID: 14944386092     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jung AC, Stagier T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 1997;12:384-9.
2. Rafieian-Kopaei M, Sewell RDE. Newer antidepressants: Analgesia and relative monoamine reuptake inhibitory potency. J Pharm Pharmacol 1994;46:1088.
3. Scott WAM. The relief of pain with an antidepressant in arthritis. Pract 1969;202:802-7.
4. Singh VP, Jain NK, Kulkami SK. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 2001;915:218-26.
5. DeLander GE, Hopkins CJ. Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception. Neuropharmacol 1987;26:1791-4.
6. D'Armour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941;72:74-9.
7. Rambadran K, Bansinath M. A critical analysis of the experimental evaluations of nociceptive reactions in animals. Pharmaceutical Res 1986;3:263-70.
8. North RA. Opioid actions on membrane ion channels. In: Herz A, editor, Opioids handbook of experimental pharmacology. Berlin: Springer Verlag; 1992.
9. Magni G. The use of antidepressants in treatment of chronic pain. Drugs 1991;42:730-48.
10. Philipp M, Ficklinger M. Psychotropic drugs in the management of chronic pain syndromes. Pharmacopsychiat 1993;26:221-34.
11. Ventafridda V, Bianchi M, Ripamonti C, Sacerdote P, De Conno F, Zecca E, et al. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 1990;43:155-62.
12. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic nephropathy. N Eng J Med 1992;326:1250-6.
13. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994;9 (Suppl 1):19-26.
14. Barg J, Belcheva MM, Levy R, McHale RJ, McLachlan JA, Johnson FE, et al. A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA. Glia 1994; 10:10-5.
15. Hamon M, Gozlan H, Bourgoin S, Benoliel JJ, Mauborgne A, Taquet H, et al. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 1987;26:531-9.
16. Richelson E. Pharmacology of antidepressants in use in the United States. J Clin Psych 1982;43:4.
17. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbard LE, Gilman AG, editors. The Pharmacological Basis of Therapeutics. McGraw-Hill company. 10th ed. 2001. p. 569-619.
18. Maitre L, Riezen HV. Amine re-uptake block by antidepressant: Virtue or vice. In: Leonard B. Spencer P, editors. Antidepressants: Thirty years on. London: CNS (Clinical Neuroscience) Publishers; 1990.
19. Sewell RDE. Supraspinal and spinal monoamine-modified function and the expression of opioid antinociception. J Psychopharmacol 1991;5:352-9.
20. Sindrup SH. Antidepressants in pain treatment. Nordic J Psychiat 1993;47:67-73.